Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 12 | 2019 | 1083 | 1.720 |
Why?
|
| Exercise | 13 | 2019 | 566 | 1.510 |
Why?
|
| Caloric Restriction | 4 | 2019 | 95 | 1.330 |
Why?
|
| Aging | 6 | 2017 | 920 | 1.090 |
Why?
|
| Aged | 32 | 2020 | 10010 | 1.040 |
Why?
|
| Pericardium | 2 | 2011 | 54 | 0.900 |
Why?
|
| Adipose Tissue | 4 | 2011 | 343 | 0.880 |
Why?
|
| Resistance Training | 3 | 2016 | 68 | 0.870 |
Why?
|
| Dietary Proteins | 1 | 2020 | 52 | 0.860 |
Why?
|
| Exercise Therapy | 5 | 2019 | 208 | 0.860 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 100 | 0.820 |
Why?
|
| Abdominal Fat | 3 | 2018 | 46 | 0.760 |
Why?
|
| Body Composition | 6 | 2019 | 355 | 0.760 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2018 | 2 | 0.750 |
Why?
|
| Scavenger Receptors, Class E | 2 | 2008 | 2 | 0.740 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 38 | 0.730 |
Why?
|
| Life Style | 3 | 2018 | 375 | 0.730 |
Why?
|
| Antigens, Neoplasm | 1 | 2018 | 44 | 0.720 |
Why?
|
| Exosomes | 1 | 2018 | 37 | 0.710 |
Why?
|
| Postmenopause | 2 | 2011 | 407 | 0.680 |
Why?
|
| Inflammation | 3 | 2010 | 512 | 0.680 |
Why?
|
| Adiposity | 4 | 2016 | 200 | 0.670 |
Why?
|
| Female | 31 | 2020 | 18849 | 0.670 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2018 | 121 | 0.660 |
Why?
|
| Geriatrics | 1 | 2018 | 96 | 0.660 |
Why?
|
| Humans | 36 | 2020 | 29158 | 0.630 |
Why?
|
| Male | 29 | 2020 | 18549 | 0.610 |
Why?
|
| Vascular Diseases | 1 | 2015 | 72 | 0.580 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 288 | 0.570 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2011 | 1267 | 0.560 |
Why?
|
| Neurons | 1 | 2018 | 389 | 0.550 |
Why?
|
| Hypertension | 5 | 2017 | 985 | 0.520 |
Why?
|
| Electrocardiography | 1 | 2018 | 574 | 0.510 |
Why?
|
| Coronary Circulation | 2 | 2016 | 35 | 0.500 |
Why?
|
| Physical Fitness | 3 | 2010 | 120 | 0.480 |
Why?
|
| Middle Aged | 17 | 2019 | 11519 | 0.480 |
Why?
|
| Lipoprotein Lipase | 1 | 2011 | 14 | 0.470 |
Why?
|
| Lipoproteins, VLDL | 1 | 2011 | 27 | 0.460 |
Why?
|
| Lipase | 1 | 2011 | 29 | 0.460 |
Why?
|
| Atherosclerosis | 3 | 2015 | 790 | 0.450 |
Why?
|
| Myocardium | 2 | 2016 | 236 | 0.440 |
Why?
|
| C-Reactive Protein | 4 | 2017 | 257 | 0.440 |
Why?
|
| Body Mass Index | 6 | 2019 | 907 | 0.420 |
Why?
|
| Exercise Tolerance | 4 | 2019 | 121 | 0.420 |
Why?
|
| Brain | 1 | 2018 | 969 | 0.420 |
Why?
|
| Aged, 80 and over | 10 | 2017 | 3908 | 0.420 |
Why?
|
| Ginkgo biloba | 1 | 2010 | 25 | 0.420 |
Why?
|
| Blood Pressure | 3 | 2015 | 896 | 0.410 |
Why?
|
| Nitrites | 1 | 2009 | 23 | 0.410 |
Why?
|
| Nitric Oxide | 2 | 2009 | 124 | 0.410 |
Why?
|
| Nitrates | 1 | 2009 | 26 | 0.400 |
Why?
|
| Plant Extracts | 1 | 2010 | 62 | 0.400 |
Why?
|
| Lipoproteins, LDL | 1 | 2009 | 72 | 0.380 |
Why?
|
| Lipoproteins, HDL | 1 | 2011 | 270 | 0.380 |
Why?
|
| Aorta | 1 | 2009 | 116 | 0.370 |
Why?
|
| Comorbidity | 1 | 2009 | 550 | 0.330 |
Why?
|
| Logistic Models | 3 | 2018 | 777 | 0.320 |
Why?
|
| Heart Failure | 3 | 2018 | 633 | 0.300 |
Why?
|
| Interleukin-6 | 3 | 2012 | 235 | 0.290 |
Why?
|
| Exercise Test | 4 | 2019 | 198 | 0.280 |
Why?
|
| Sex Factors | 2 | 2017 | 694 | 0.270 |
Why?
|
| Age Factors | 3 | 2018 | 1182 | 0.230 |
Why?
|
| Gait | 3 | 2017 | 90 | 0.230 |
Why?
|
| Oxygen Consumption | 4 | 2019 | 142 | 0.220 |
Why?
|
| Cardiovascular Diseases | 3 | 2017 | 1096 | 0.210 |
Why?
|
| Polymorphism, Genetic | 2 | 2014 | 223 | 0.210 |
Why?
|
| Hand Strength | 2 | 2012 | 87 | 0.210 |
Why?
|
| Weight Loss | 2 | 2015 | 404 | 0.210 |
Why?
|
| Proteins | 1 | 2020 | 147 | 0.200 |
Why?
|
| North Carolina | 3 | 2015 | 1734 | 0.200 |
Why?
|
| Chronic Disease | 3 | 2010 | 384 | 0.200 |
Why?
|
| Intra-Abdominal Fat | 3 | 2018 | 67 | 0.190 |
Why?
|
| Sepharose | 1 | 2018 | 5 | 0.190 |
Why?
|
| Biotinylation | 1 | 2018 | 10 | 0.190 |
Why?
|
| Mobility Limitation | 3 | 2014 | 183 | 0.190 |
Why?
|
| Body Fat Distribution | 1 | 2018 | 39 | 0.180 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 699 | 0.180 |
Why?
|
| Risk Factors | 7 | 2017 | 3708 | 0.180 |
Why?
|
| Research | 1 | 2018 | 76 | 0.180 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 69 | 0.180 |
Why?
|
| Protein Binding | 1 | 2018 | 198 | 0.180 |
Why?
|
| Cell Separation | 1 | 2018 | 90 | 0.180 |
Why?
|
| Geriatric Assessment | 4 | 2016 | 358 | 0.170 |
Why?
|
| Avitaminosis | 1 | 2017 | 3 | 0.170 |
Why?
|
| Disability Evaluation | 2 | 2019 | 223 | 0.170 |
Why?
|
| Vitamin K 1 | 1 | 2017 | 14 | 0.170 |
Why?
|
| Treatment Outcome | 3 | 2019 | 3153 | 0.170 |
Why?
|
| Lysine | 1 | 2017 | 26 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2018 | 1246 | 0.170 |
Why?
|
| Time Factors | 2 | 2015 | 2091 | 0.170 |
Why?
|
| Heart | 1 | 2018 | 203 | 0.160 |
Why?
|
| Gene Expression | 1 | 2018 | 342 | 0.160 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2016 | 25 | 0.150 |
Why?
|
| Dobutamine | 1 | 2016 | 51 | 0.150 |
Why?
|
| Elasticity | 1 | 2015 | 36 | 0.150 |
Why?
|
| Stroke Volume | 1 | 2018 | 304 | 0.150 |
Why?
|
| Ankle Brachial Index | 1 | 2015 | 44 | 0.150 |
Why?
|
| Waist Circumference | 1 | 2015 | 94 | 0.150 |
Why?
|
| African Continental Ancestry Group | 1 | 2017 | 413 | 0.150 |
Why?
|
| Continental Population Groups | 1 | 2017 | 249 | 0.150 |
Why?
|
| Forecasting | 1 | 2015 | 138 | 0.140 |
Why?
|
| Heart Ventricles | 1 | 2016 | 138 | 0.140 |
Why?
|
| Heart Rate | 1 | 2017 | 355 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2017 | 171 | 0.140 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2014 | 35 | 0.140 |
Why?
|
| Single-Blind Method | 2 | 2012 | 181 | 0.140 |
Why?
|
| Forced Expiratory Volume | 1 | 2014 | 115 | 0.140 |
Why?
|
| European Continental Ancestry Group | 2 | 2017 | 1356 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2015 | 472 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 558 | 0.130 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 486 | 0.130 |
Why?
|
| Triglycerides | 2 | 2011 | 221 | 0.130 |
Why?
|
| Activities of Daily Living | 2 | 2014 | 237 | 0.120 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2012 | 10 | 0.120 |
Why?
|
| Gene Frequency | 2 | 2014 | 276 | 0.120 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 78 | 0.120 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2014 | 203 | 0.120 |
Why?
|
| Perfusion | 1 | 2011 | 62 | 0.120 |
Why?
|
| DNA Primers | 1 | 2011 | 91 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2018 | 931 | 0.110 |
Why?
|
| Base Sequence | 1 | 2011 | 237 | 0.110 |
Why?
|
| Linear Models | 2 | 2010 | 453 | 0.110 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 175 | 0.110 |
Why?
|
| Hemodynamics | 1 | 2011 | 177 | 0.110 |
Why?
|
| Aortic Diseases | 1 | 2011 | 57 | 0.110 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 79 | 0.110 |
Why?
|
| Genotype | 2 | 2014 | 839 | 0.110 |
Why?
|
| Prospective Studies | 2 | 2015 | 2028 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2009 | 257 | 0.100 |
Why?
|
| Plethysmography | 1 | 2009 | 9 | 0.100 |
Why?
|
| Coronary Disease | 1 | 2011 | 239 | 0.100 |
Why?
|
| Multienzyme Complexes | 1 | 2009 | 9 | 0.100 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2009 | 10 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2015 | 1362 | 0.100 |
Why?
|
| Blood Flow Velocity | 1 | 2009 | 63 | 0.100 |
Why?
|
| Absorptiometry, Photon | 2 | 2019 | 131 | 0.100 |
Why?
|
| Probability | 1 | 2009 | 159 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 2175 | 0.090 |
Why?
|
| Double-Blind Method | 1 | 2010 | 537 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2010 | 179 | 0.090 |
Why?
|
| Exons | 1 | 2008 | 54 | 0.090 |
Why?
|
| Thinness | 1 | 2008 | 26 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1575 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 201 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2011 | 1751 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 200 | 0.090 |
Why?
|
| Genetic Testing | 1 | 2008 | 100 | 0.090 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 119 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 533 | 0.090 |
Why?
|
| Lipids | 1 | 2009 | 224 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 1370 | 0.080 |
Why?
|
| Incidence | 1 | 2010 | 1162 | 0.080 |
Why?
|
| Kidney | 1 | 2010 | 477 | 0.080 |
Why?
|
| Body Weight | 1 | 2008 | 304 | 0.080 |
Why?
|
| Overweight | 1 | 2008 | 257 | 0.080 |
Why?
|
| Subcutaneous Fat, Abdominal | 2 | 2018 | 14 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2016 | 2962 | 0.080 |
Why?
|
| Adult | 2 | 2011 | 8705 | 0.060 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 371 | 0.050 |
Why?
|
| Health Education | 2 | 2014 | 136 | 0.050 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 112 | 0.050 |
Why?
|
| Executive Function | 1 | 2019 | 58 | 0.050 |
Why?
|
| Fatigue | 1 | 2019 | 75 | 0.050 |
Why?
|
| Thigh | 1 | 2018 | 37 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 399 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2018 | 131 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 39 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 48 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2017 | 93 | 0.040 |
Why?
|
| Echocardiography, Stress | 1 | 2016 | 23 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2019 | 498 | 0.040 |
Why?
|
| Microcirculation | 1 | 2016 | 59 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2016 | 37 | 0.040 |
Why?
|
| Calcinosis | 1 | 2017 | 180 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2016 | 55 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 146 | 0.040 |
Why?
|
| Cognition | 1 | 2019 | 538 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 769 | 0.040 |
Why?
|
| Spirometry | 1 | 2014 | 35 | 0.040 |
Why?
|
| Brachial Artery | 1 | 2014 | 76 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 258 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 483 | 0.030 |
Why?
|
| Stroke | 1 | 2017 | 543 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 64 | 0.030 |
Why?
|
| Dinoprost | 1 | 2009 | 11 | 0.030 |
Why?
|
| Nitrogen Oxides | 1 | 2009 | 6 | 0.020 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2009 | 23 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 45 | 0.020 |
Why?
|
| Antioxidants | 1 | 2009 | 113 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2009 | 175 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 489 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 451 | 0.020 |
Why?
|
| United States | 1 | 2015 | 3752 | 0.020 |
Why?
|
| Health Status | 1 | 2008 | 399 | 0.020 |
Why?
|
| Animals | 1 | 2010 | 7519 | 0.010 |
Why?
|